Identifying neuromodulation targets for pain in the human brain
识别人脑疼痛的神经调节目标
基本信息
- 批准号:10450987
- 负责人:
- 金额:$ 26.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-03-15 至 2024-02-28
- 项目状态:已结题
- 来源:
- 关键词:Adverse effectsAnalgesicsAtlasesBase of the BrainBrainBrain hemorrhageBrain regionClinical TrialsDataData SetDatabasesDependenceDevelopmentDystoniaEnrollmentFoxesFutureHumanIschemic StrokeLesionLinkLiteratureLocationMagnetic Resonance ImagingMapsMental DepressionMental disordersMetabolismMethodsMotor CortexNeuroanatomyNeurologicNeurologic SymptomsPainPain MapPain managementParkinson DiseasePatientsPharmacologyQuality of lifeQuestionnairesReportingRestSymptomsTestingThalamic structureTranscranial magnetic stimulationTremoraddictionbasecentral painclinically significantcohortfluorodeoxyglucose positron emission tomographyimprovedmetabolic imagingnervous system disorderneuroimagingneuropsychiatric symptomneuroregulationnovel strategiespain reliefpainful neuropathypost strokepost stroke painprospectivepsychiatric symptomside effectstroke outcomethalamic paintherapeutic target
项目摘要
Identifying neuromodulation targets for pain in the human brain
Neuropathic pain is prevalent across many different neurological and psychiatric disorders and has one of the
largest adverse effects on quality of life. Pharmacological pain treatments often have limited efficacy and
undesirable side effects, including dependence and addiction. Neuromodulation treatments such as transcranial
magnetic stimulation show promise for pain while avoiding the side effects associated with pain medications. An
obstacle to improving neuromodulation treatment is identifying the human brain regions responsible for pain.
Traditional functional neuroimaging studies only identify correlates of pain which could be causing symptoms,
compensating for symptoms, or simply serving as a marker of symptoms. This ambiguity is a problem when
seeking to identify therapeutic targets. Unlike functional neuroimaging, lesion studies allow for casual links
between symptoms and human neuroanatomy. The PI has developed and validated a new method to identify
neuromodulation targets in the human brain based on brain lesions and a map of human brain connectivity.
Called lesion network mapping, this approach has been used to map numerous neurological and psychiatric
symptoms to brain networks (Fox 2018, NEJM). Brain networks identified using this approach have proven to
be effective neuromodulation targets for symptoms such as tremor, Parkinson’s disease, dystonia, and
depression. Our preliminary data suggests this method is equally valuable for mapping pain, including
identification of therapeutic targets. Here, we will use this approach to map pain to a human brain circuit based
on lesion locations previously reported to cause pain (Aim 1), a dedicated dataset focused on thalamic lesions
causing or not causing pain (Aim 2), and a prospective dataset of patients longitudinally assessed for
development of post-stroke pain (Aim 3). We hypothesize that; (1) lesions causing pain will map to a common
brain network; (2) this network will show abnormal metabolism in patients with post stroke pain, (3) this network
will predict who will develop post-stroke pain; and (4) this pain network will include primary motor cortex, our
best validated neuromodulation target for pain. Completion of these aims will identify a candidate human brain
network causally linked to pain. Once identified, this network can be validated in future trials with more detailed
characterization of post stroke pain and used as an improved target for neuromodulation that can be tested in
clinical trials.
确定人脑中疼痛的神经调节靶点
神经病理性疼痛在许多不同的神经和精神障碍中普遍存在,并具有
对生活质量的最大不利影响。药物治疗疼痛的效果往往有限,而且
不良副作用,包括依赖和上瘾。神经调节治疗,如经颅
磁刺激显示出止痛的前景,同时避免了与止痛药相关的副作用。一个
改善神经调节治疗的障碍是确定人类大脑中负责疼痛的区域。
传统的功能神经成像研究只确定可能导致症状的疼痛的相关性,
补偿症状,或简单地作为症状的标志。这种模棱两可是一个问题,当
寻求确定治疗靶点。与功能神经成像不同,病变研究允许随意联系
症状和人类神经解剖学之间的关系。PI已经开发并验证了一种新的识别方法
基于大脑损伤和人脑连通性地图的人脑神经调节目标。
这种方法被称为病变网络映射,已经被用于绘制许多神经学和精神病学的地图
症状到大脑网络(福克斯2018,NEJM)。使用这种方法识别的大脑网络已被证明
成为治疗震颤、帕金森氏症、肌张力障碍等症状的有效神经调节靶点
抑郁症。我们的初步数据表明,这种方法在绘制疼痛地图方面同样有价值,包括
确定治疗靶点。在这里,我们将使用这种方法将疼痛映射到人类大脑的一个基于
关于先前报告的引起疼痛的病变位置(AIM 1),这是一个专注于丘脑病变的专用数据集
引起或不引起疼痛(目标2),以及纵向评估的患者的预期数据集
中风后疼痛的发展(目标3)。我们假设:(1)引起疼痛的损伤将映射到共同的
大脑网络;(2)这个网络会显示中风后疼痛患者的代谢异常,(3)这个网络
将预测谁会出现中风后疼痛;以及(4)这个疼痛网络将包括初级运动皮质,我们的
最有效的疼痛神经调节靶点。完成这些目标将确定一个候选的人脑
网络与痛苦有着因果关系。一旦确定,此网络可以在未来的试验中进行验证,并提供更详细的信息
卒中后疼痛的特征,并用作神经调节的改进靶点,可在
临床试验。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL D FOX其他文献
MICHAEL D FOX的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL D FOX', 18)}}的其他基金
Identifying neuromodulation targets for pain in the human brain
识别人脑疼痛的神经调节目标
- 批准号:
10589120 - 财政年份:2022
- 资助金额:
$ 26.85万 - 项目类别:
Using Brain Lesions and Deep Brain Stimulation to Identify an Epilepsy Circuit
利用脑损伤和深部脑刺激来识别癫痫回路
- 批准号:
10634692 - 财政年份:2022
- 资助金额:
$ 26.85万 - 项目类别:
Using brain lesions and deep brain stimulation to identify an epilepsy circuit
利用脑损伤和深部脑刺激来识别癫痫回路
- 批准号:
10501784 - 财政年份:2022
- 资助金额:
$ 26.85万 - 项目类别:
Targeted modulation of symptom-specific brain circuits with transcranial magnetic stimulation
通过颅磁刺激有针对性地调节症状特异性脑回路
- 批准号:
10369674 - 财政年份:2021
- 资助金额:
$ 26.85万 - 项目类别:
Transdiagnostic memory, mood and motor circuits in Alzheimer's and neurodegenerative disease
阿尔茨海默病和神经退行性疾病的跨诊断记忆、情绪和运动回路
- 批准号:
10358675 - 财政年份:2021
- 资助金额:
$ 26.85万 - 项目类别:
Targeted modulation of symptom-specific brain circuits with transcranial magnetic stimulation
通过颅磁刺激有针对性地调节症状特异性脑回路
- 批准号:
10195920 - 财政年份:2021
- 资助金额:
$ 26.85万 - 项目类别:
Using human brain connectivity to identify the causal neuroanatomical substrate of depression symptoms
利用人脑连接来识别抑郁症状的因果神经解剖学基础
- 批准号:
10646488 - 财政年份:2017
- 资助金额:
$ 26.85万 - 项目类别:
Using human brain connectivity to identify the causal neuroanatomical substrate of depression symptoms
利用人脑连接来识别抑郁症状的因果神经解剖学基础
- 批准号:
10242694 - 财政年份:2017
- 资助金额:
$ 26.85万 - 项目类别:
Using human brain connectivity to identify the causal neuroanatomical substrate of depression symptoms
利用人脑连接来识别抑郁症状的因果神经解剖学基础
- 批准号:
9766881 - 财政年份:2017
- 资助金额:
$ 26.85万 - 项目类别:
Using human brain connectivity to identify the causal neuroanatomical substrate of depression symptoms
利用人脑连接来识别抑郁症状的因果神经解剖学基础
- 批准号:
10290232 - 财政年份:2017
- 资助金额:
$ 26.85万 - 项目类别:
相似海外基金
Planning Study for the Development of Sigma 2 ligands as Analgesics
Sigma 2 配体镇痛药开发规划研究
- 批准号:
10641500 - 财政年份:2023
- 资助金额:
$ 26.85万 - 项目类别:
Designing and validating optimal nonaddictive analgesics using the CANDO paradigm
使用 CANDO 范式设计和验证最佳的非成瘾性镇痛药
- 批准号:
10485593 - 财政年份:2023
- 资助金额:
$ 26.85万 - 项目类别:
Identification of botanical hHv1 channel blockers as analgesics for neuropathic pain
植物 hHv1 通道阻滞剂作为神经性疼痛镇痛药的鉴定
- 批准号:
10728526 - 财政年份:2023
- 资助金额:
$ 26.85万 - 项目类别:
Development of LPA5 Antagonists as Analgesics
LPA5 拮抗剂镇痛药的开发
- 批准号:
10638278 - 财政年份:2023
- 资助金额:
$ 26.85万 - 项目类别:
Designed Multiple Ligands as Non-opioid Analgesics for Treating Chronic Pain
设计多种配体作为非阿片类镇痛药,用于治疗慢性疼痛
- 批准号:
10621646 - 财政年份:2023
- 资助金额:
$ 26.85万 - 项目类别:
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
- 批准号:
10425794 - 财政年份:2022
- 资助金额:
$ 26.85万 - 项目类别:
Elucidation of the mechanism of pain suppression by exercise and development of new analgesics
阐明运动镇痛机制及开发新型镇痛药
- 批准号:
22K19602 - 财政年份:2022
- 资助金额:
$ 26.85万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Allosteric Targeting of Cannabinoid CB1 Receptor to Develop Non-Addictive Small Molecule Analgesics
大麻素 CB1 受体变构靶向开发非成瘾性小分子镇痛药
- 批准号:
10512672 - 财政年份:2022
- 资助金额:
$ 26.85万 - 项目类别:
A novel clinically-relevant mouse model of chronic overlapping pain conditions for screening analgesics
用于筛选镇痛药的新型临床相关慢性重叠疼痛小鼠模型
- 批准号:
10821681 - 财政年份:2022
- 资助金额:
$ 26.85万 - 项目类别:
Single-administration microneedles with controlled sustained release of non-opioid analgesics to treat osteoarthritis pain
单次给药微针控制缓释非阿片类镇痛药治疗骨关节炎疼痛
- 批准号:
10721752 - 财政年份:2022
- 资助金额:
$ 26.85万 - 项目类别:














{{item.name}}会员




